#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Structural and Functional Studies of Nonstructural Protein 2 of the Hepatitis C Virus Reveal Its Key Role as Organizer of Virion Assembly


Non-structural protein 2 (NS2) plays an important role in hepatitis C virus (HCV) assembly, but neither the exact contribution of this protein to the assembly process nor its complete structure are known. In this study we used a combination of genetic, biochemical and structural methods to decipher the role of NS2 in infectious virus particle formation. A large panel of NS2 mutations targeting the N-terminal membrane binding region was generated. They were selected based on a membrane topology model that we established by determining the NMR structures of N-terminal NS2 transmembrane segments. Mutants affected in virion assembly, but not RNA replication, were selected for pseudoreversion in cell culture. Rescue mutations restoring virus assembly to various degrees emerged in E2, p7, NS3 and NS2 itself arguing for an interaction between these proteins. To confirm this assumption we developed a fully functional JFH1 genome expressing an N-terminally tagged NS2 demonstrating efficient pull-down of NS2 with p7, E2 and NS3 and, to a lower extent, NS5A. Several of the mutations blocking virus assembly disrupted some of these interactions that were restored to various degrees by those pseudoreversions that also restored assembly. Immunofluorescence analyses revealed a time-dependent NS2 colocalization with E2 at sites close to lipid droplets (LDs) together with NS3 and NS5A. Importantly, NS2 of a mutant defective in assembly abrogates NS2 colocalization around LDs with E2 and NS3, which is restored by a pseudoreversion in p7, whereas NS5A is recruited to LDs in an NS2-independent manner. In conclusion, our results suggest that NS2 orchestrates HCV particle formation by participation in multiple protein-protein interactions required for their recruitment to assembly sites in close proximity of LDs.


Vyšlo v časopise: Structural and Functional Studies of Nonstructural Protein 2 of the Hepatitis C Virus Reveal Its Key Role as Organizer of Virion Assembly. PLoS Pathog 6(12): e32767. doi:10.1371/journal.ppat.1001233
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001233

Souhrn

Non-structural protein 2 (NS2) plays an important role in hepatitis C virus (HCV) assembly, but neither the exact contribution of this protein to the assembly process nor its complete structure are known. In this study we used a combination of genetic, biochemical and structural methods to decipher the role of NS2 in infectious virus particle formation. A large panel of NS2 mutations targeting the N-terminal membrane binding region was generated. They were selected based on a membrane topology model that we established by determining the NMR structures of N-terminal NS2 transmembrane segments. Mutants affected in virion assembly, but not RNA replication, were selected for pseudoreversion in cell culture. Rescue mutations restoring virus assembly to various degrees emerged in E2, p7, NS3 and NS2 itself arguing for an interaction between these proteins. To confirm this assumption we developed a fully functional JFH1 genome expressing an N-terminally tagged NS2 demonstrating efficient pull-down of NS2 with p7, E2 and NS3 and, to a lower extent, NS5A. Several of the mutations blocking virus assembly disrupted some of these interactions that were restored to various degrees by those pseudoreversions that also restored assembly. Immunofluorescence analyses revealed a time-dependent NS2 colocalization with E2 at sites close to lipid droplets (LDs) together with NS3 and NS5A. Importantly, NS2 of a mutant defective in assembly abrogates NS2 colocalization around LDs with E2 and NS3, which is restored by a pseudoreversion in p7, whereas NS5A is recruited to LDs in an NS2-independent manner. In conclusion, our results suggest that NS2 orchestrates HCV particle formation by participation in multiple protein-protein interactions required for their recruitment to assembly sites in close proximity of LDs.


Zdroje

1. LevreroM

2006 Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene 25 3834 3847

2. SeeffLB

2002 Natural history of chronic hepatitis C. Hepatology 36 S35 S46

3. BartenschlagerR

FreseM

PietschmannT

2004 Novel insights into hepatitis C virus replication and persistence. Adv Virus Res 63 71 180

4. MoradpourD

PeninF

RiceCM

2007 Replication of hepatitis C virus. Nat Rev Microbiol 5 453 463

5. JonesCT

MurrayCL

EastmanDK

TasselloJ

RiceCM

2007 Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J Virol 81 8374 8383

6. JiraskoV

MontserretR

AppelN

JanvierA

EustachiL

2008 Structural and functional characterization of nonstructural protein 2 for its role in hepatitis C virus assembly. J Biol Chem 283 28546 28562

7. LohmannV

KörnerF

KochJO

HerianU

TheilmannL

1999 Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285 110 113

8. AppelN

SchallerT

PeninF

BartenschlagerR

2006 From structure to function: new insights into hepatitis C virus RNA replication. J Biol Chem 281 9833 9836

9. WakitaT

PietschmannT

KatoT

DateT

MiyamotoM

2005 Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11 791 796

10. KaulA

WoerzI

MeulemanP

Leroux-RoelsG

BartenschlagerR

2007 Cell culture adaptation of hepatitis C virus and in vivo viability of an adapted variant. J Virol 81 13168 13179

11. DelgrangeD

PillezA

CastelainS

CocquerelL

RouilleY

2007 Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins. J Gen Virol 88 2495 2503

12. ZhongJ

GastaminzaP

ChungJ

StamatakiZ

IsogawaM

2006 Persistent hepatitis C virus infection in vitro: coevolution of virus and host. J Virol 80 11082 11093

13. LindenbachBD

EvansMJ

SyderAJ

WolkB

TellinghuisenTL

2005 Complete replication of hepatitis C virus in cell culture. Science 309 623 626

14. PietschmannT

KaulA

KoutsoudakisG

ShavinskayaA

KallisS

2006 Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci U S A 103 7408 7413

15. Carrere-KremerS

MontpellierC

LorenzoL

BrulinB

CocquerelL

2004 Regulation of hepatitis C virus polyprotein processing by signal peptidase involves structural determinants at the p7 sequence junctions. J Biol Chem 279 41384 41392

16. MontserretR

SaintN

VanbelleC

SalvayAG

SimorreJP

2010 NMR structure and ion channel activity of the p7 protein from hepatitis C virus. J Biol Chem 285 31446 61

17. LuikP

ChewC

AittoniemiJ

ChangJ

WentworthPJr

2009 The 3-dimensional structure of a hepatitis C virus p7 ion channel by electron microscopy. Proc Natl Acad Sci U S A 106 12712 12716

18. GriffinSD

BealesLP

ClarkeDS

WorsfoldO

EvansSD

2003 The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine. FEBS Lett 535 34 38

19. ClarkeD

GriffinS

BealesL

GelaisCS

BurgessS

2006 Evidence for the formation of a heptameric ion channel complex by the hepatitis C virus p7 protein in vitro. J Biol Chem 281 37057 37068

20. SakaiA

ClaireMS

FaulkK

GovindarajanS

EmersonSU

2003 The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences. Proc Natl Acad Sci U S A 100 11646 11651

21. SteinmannE

PeninF

KallisS

PatelAH

BartenschlagerR

2007 Hepatitis C Virus p7 Protein Is Crucial for Assembly and Release of Infectious Virions. PLoS Pathog 3 e103

22. GriffinS

StGelaisC

OwsiankaAM

PatelAH

RowlandsD

2008 Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel. Hepatology 48 1779 1790

23. LorenzIC

MarcotrigianoJ

DentzerTG

RiceCM

2006 Structure of the catalytic domain of the hepatitis C virus NS2-3 protease. Nature 442 831 835

24. WelbournS

GreenR

GamacheI

DandacheS

LohmannV

2005 Hepatitis C virus NS2/3 processing is required for NS3 stability and viral RNA replication. J Biol Chem 280 29604 29611

25. PhanT

BeranRK

PetersC

LorenzIC

LindenbachBD

2009 Hepatitis C virus NS2 protein contributes to virus particle assembly via opposing epistatic interactions with the E1-E2 glycoprotein and NS3-NS4A enzyme complexes. J Virol 83 8379 8395

26. DentzerTG

LorenzIC

EvansMJ

RiceCM

2009 Determinants of the hepatitis C virus nonstructural protein 2 protease domain required for production of infectious virus. J Virol 83 12702 12713

27. YiM

MaY

YatesJ

LemonSM

2009 Trans-complementation of an NS2 defect in a late step in hepatitis C virus (HCV) particle assembly and maturation. PLoS Pathog 5 e1000403

28. YamagaAK

OuJH

2002 Membrane topology of the hepatitis C virus NS2 protein. J Biol Chem 277 33228 33234

29. TellinghuisenTL

FossKL

TreadawayJ

2008 Regulation of hepatitis C virion production via phosphorylation of the NS5A protein. PLoS Pathog 4 e1000032

30. AppelN

ZayasM

MillerS

Krijnse-LockerJ

SchallerT

2008 Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog 4 e1000035

31. MiyanariY

AtsuzawaK

UsudaN

WatashiK

HishikiT

2007 The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 9 1089 1097

32. MasakiT

SuzukiR

MurakamiK

AizakiH

IshiiK

2008 Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles. J Virol 82 7964 7976

33. HinsonER

CresswellP

2009 The antiviral protein, viperin, localizes to lipid droplets via its N-terminal amphipathic alpha-helix. Proc Natl Acad Sci U S A 106 20452 20457

34. BrassV

BieckE

MontserretR

WolkB

HellingsJA

2002 An amino-terminal amphipathic alpha-helix mediates membrane association of the hepatitis C virus nonstructural protein 5A. J Biol Chem 277 8130 8139

35. TellinghuisenTL

MarcotrigianoJ

GorbalenyaAE

RiceCM

2004 The NS5A protein of hepatitis C virus is a zinc metalloprotein. J Biol Chem 279 48576 48587

36. TellinghuisenTL

MarcotrigianoJ

RiceCM

2005 Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase. Nature 435 374 379

37. HuangH

SunF

OwenDM

LiW

ChenY

2007 Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc Natl Acad Sci U S A 104 5848 5853

38. ShavinskayaA

BoulantS

PeninF

McLauchlanJ

BartenschlagerR

2007 The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly. J Biol Chem 282 37158 37169

39. BoulantS

Targett-AdamsP

McLauchlanJ

2007 Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus. J Gen Virol 88 2204 2213

40. JonesDM

McLauchlanJ

2010 Hepatitis C virus: assembly and release of virus particles. J Biol Chem 285 22733 9

41. RidderA

SkupjenP

UnterreitmeierS

LangoschD

2005 Tryptophan supports interaction of transmembrane helices. J Mol Biol 354 894 902

42. YauWM

WimleyWC

GawrischK

WhiteSH

1998 The preference of tryptophan for membrane interfaces. Biochemistry 37 14713 14718

43. GransethE

Von HeijneG

ElofssonA

2005 A study of the membrane-water interface region of membrane proteins. J Mol Biol 346 377 385

44. MurrayCL

JonesCT

TasselloJ

RiceCM

2007 Alanine scanning of the hepatitis C virus core protein reveals numerous residues essential for production of infectious virus. J Virol 81 10220 10231

45. YiM

MaY

YatesJ

LemonSM

2007 Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J Virol 81 629 638

46. ScheelTK

GottweinJM

JensenTB

PrentoeJC

HoeghAM

2008 Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization. Proc Natl Acad Sci U S A 105 997 1002

47. KatoT

ChoiY

ElmowalidG

SappRK

BarthH

2008 Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation. Hepatology 48 732 740

48. JensenTB

GottweinJM

ScheelTKH

HoeghAM

Eugen-OlsenJ

2008 Highly Efficient JFH1-Based Cell-Culture System for Hepatitis C Virus Genotype 5a: Failure of Homologous Neutralizing-Antibody Treatment to Control Infection. J Inf Dis 198 1756 1765

49. GottweinJM

ScheelTKH

JensenTB

LademannJB

PrentoeJC

2009 Development and Characterization of Hepatitis C Virus Genotype 1-7 Cell Culture Systems: Role of CD81 and Scavenger Receptor Class B Type I and Effect of Antiviral Drugs. Hepatology 49 364 377

50. CiczoraY

CallensN

PeninF

PecheurEI

DubuissonJ

2007 Transmembrane domains of hepatitis C virus envelope glycoproteins: Residues involved in E1E2 heterodimerization and involvement of these domains in virus entry. J Virol 81 2372 2381

51. MaY

YatesJ

LiangY

LemonSM

YiM

2008 NS3 helicase domains involved in infectious intracellular hepatitis C virus particle assembly. J Virol 82 7624 7639

52. DubuissonJ

RiceCM

1996 Hepatitis C virus glycoprotein folding: Disulfide bond formation and association with calnexin. J Virol 70 778 786

53. ErdtmannL

FranckN

LeratH

Le SeyecJ

GilotD

2003 The hepatitis C virus NS2 protein is an inhibitor of CIDE-B-induced apoptosis. J Biol Chem 278 18256 18264

54. HallAM

BruntEM

ChenZJ

ViswakarmaN

ReddyJK

2010 Dynamic and differential regulation of proteins that coat lipid droplets in fatty liver dystrophic mice. J Lipid Res 51 554 563

55. CombetC

BlanchetC

GeourjonC

DeleageG

2000 NPS@: Network Protein Sequence Analysis. Trends Biochem Sci 25 147 150

56. CombetC

GarnierN

CharavayC

GrandoD

CrisanD

2007 euHCVdb: the European hepatitis C virus database. Nucleic Acids Res 35 D363 D366

57. ThompsonJD

HigginsDG

GibsonTJ

1994 Clustal-W - Improving the Sensitivity of Progressive Multiple Sequence Alignment Through Sequence Weighting, Position-Specific Gap Penalties and Weight Matrix Choice. Nucleic Acids Res 22 4673 4680

58. WimleyWC

WhiteSH

1996 Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat Struct Biol 3 842 848

59. FriebeP

BoudetJ

SimorreJP

BartenschlagerR

2005 Kissing-loop interaction in the 3′ end of the hepatitis C virus genome essential for RNA replication. J Virol 79 380 392

60. BlightKJ

McKeatingJA

RiceCM

2002 Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76 13001 13014

61. BrassV

BerkeJM

MontserretR

BlumHE

PeninF

2008 Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex. Proc Natl Acad Sci U S A 105 14545 14550

62. KoutsoudakisG

HerrmannE

KallisS

BartenschlagerR

PietschmannT

2007 The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells. J Virol 81 588 598

63. KaulA

WorzI

BartenschlagerR

2009 Adaptation of the hepatitis C virus to cell culture. Methods Mol Biol 510 361 372

64. KochJO

BartenschlagerR

1999 Modulation of hepatitis C virus NS5A hyperphosphorylation by nonstructural proteins NS3, NS4A, and NS4B. J Virol 73 7138 7146

65. BartenschlagerR

LohmannV

WilkinsonT

KochJO

1995 Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation. J Virol 69 7519 7528

66. MoradpourD

KaryP

RiceCM

BlumHE

1998 Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins. Hepatology 28 192 201

67. HumphreyW

DalkeA

SchultenK

1996 VMD: Visual molecular dynamics. J Mol Graphics 14 33 8, 27-8

68. Op De BeeckA

MontserretR

DuvetS

CocquerelL

CacanR

2000 The transmembrane domains of hepatitis C virus envelope glycoproteins E1 and E2 play a major role in heterodimerization. J Biol Chem 275 31428 31437

69. MerutkaG

DysonHJ

WrightPE

1995 Random Coil H-1 Chemical-Shifts Obtained As A Function of Temperature and Trifluoroethanol Concentration for the Peptide Series Ggxgg. J Biomol Nmr 5 14 24

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 12
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#